PHARM.AS Pharming Group (EURONEXT) pre-market 09 Mar 2026: Q4 earnings focus
Pharming Group (PHARM.AS) enters the pre-market session on 09 Mar 2026 ahead of its Q4 and FY2025 results due 12 Mar 2026, and investors will watch revenue and guidance closely. Our earnings spotlight flags €1.33 as the current price and €376.00M implied FY2025 revenue in recent reports. This pre-market note frames the numbers, catalysts, and what a surprise could mean for trading on EURONEXT in Europe.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
